Niagen Bioscience renames research program, cites 300+ collaborations Jun 2, 2026 08:33AM
Niagen Bioscience (NAGE) PT Lowered to $11 at H.C. Wainwright May 11, 2026 07:13AM
Niagen Bioscience, Inc. (NAGE) Misses Q1 EPS by 1c, offers outlook May 6, 2026 04:55PM
Niagen Bioscience launches telehealth platform with at-home injection kit May 4, 2026 08:32AM
Niagen Bioscience secures USP monograph for nicotinamide riboside chloride Apr 9, 2026 08:32AM


Mar 31, 2026 08:35AM Niagen Bioscience partners with OneSpaWorld for cruise ship clinics
Mar 17, 2026 08:33AM Niagen Bioscience reaches 300 research agreements milestone
Mar 4, 2026 04:30PM After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
Mar 4, 2026 04:04PM Niagen Bioscience, Inc. (NAGE) Tops Q4 EPS by 3c, offers outlook
Feb 26, 2026 07:03AM Niagen Bioscience sells ChromaDex Reference Standards to LGC for cash
Feb 25, 2026 08:32AM Niagen Bioscience receives US patent for IV nicotinamide riboside
Jan 15, 2026 08:34AM Niagen Bioscience enables HSA/FSA payments for Tru Niagen supplement
Dec 22, 2025 08:33AM Niagen Bioscience acquires nicotinamide riboside patent portfolio
Nov 4, 2025 04:53PM Niagen Bioscience, Inc. (NAGE) Tops Q3 EPS by 3c, offers outlook
Oct 7, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE)
Oct 6, 2025 08:33AM Niagen Bioscience raises 2025 sales growth outlook to 25%-30%
Oct 1, 2025 08:34AM Niagen Bioscience expands IV product to over 900 clinics nationwide
Aug 11, 2025 06:40AM Niagen Bioscience (NAGE) PT Raised to $12 at H.C. Wainwright
Aug 6, 2025 05:12PM Niagen Bioscience, Inc. (NAGE) Tops Q2 EPS by 2c
Jul 8, 2025 08:32AM Niagen Bioscience secures exclusive license for Parkinson's therapy
Jun 10, 2025 06:28AM Niagen Bioscience (NAGE) PT Raised to $16 at Canaccord Genuity
Jun 9, 2025 08:56AM Niagen Bioscience (NAGE) stock rises following positive clinical study
Jun 9, 2025 08:37AM Niagen Bioscience (NAGE) announces positive study on Niagen
May 7, 2025 06:16PM Niagen Bioscience, Inc. (NAGE) Tops Q1 EPS by 4c
May 5, 2025 08:33AM Niagen Bioscience (NAGE) announces Niagen IV is available in nearly 600 clinics
Apr 29, 2025 08:33AM Niagen Bioscience (NAGE) appoints Dr. Pinchas Cohen to SAB
Apr 8, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on (NAGE)
Apr 7, 2025 08:32AM Niagen Bioscience (NAGE) Confirms Its Operations Remain Resilient Amid New Tariff Developments
Mar 31, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE)
Mar 20, 2025 08:35AM Niagen Bioscience (NAGE) Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms
Mar 13, 2025 08:34AM ChromaDex (CDXC) rebrands as Niagen Bioscience (NAGE)